Susana Conde Ceide Selected Research

5- tert- butyl- N- cyclopropyl- 2- methoxy- 3- (2- (4- (2- morpholin- 4- ylethoxy)naphthalen- 1- yl)- 2- oxoacetylamino)benzamide

4/2010

KR-003048, a potent, orally active inhibitor of p38 mitogen-activated protein kinase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Susana Conde Ceide Research Topics

Disease

1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2010
1	Edema (Dropsy) 04/2010
1	Chronic Obstructive Pulmonary Disease (COPD) 04/2010
1	Experimental Arthritis 04/2010
1	Rheumatoid Arthritis 04/2010
1	Inflammation (Inflammations) 04/2010
1	Osteoporosis 04/2010
1	Epilepsy (Aura) 07/2004
1	Pain (Aches) 07/2004
1	Status Epilepticus (Complex Partial Status Epilepticus) 07/2004

Drug/Important Bio-Agent (IBA)

1	CarrageenanIBA 04/2010
1	5- tert- butyl- N- cyclopropyl- 2- methoxy- 3- (2- (4- (2- morpholin- 4- ylethoxy)naphthalen- 1- yl)- 2- oxoacetylamino)benzamideIBA 04/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2010
1	CytokinesIBA 04/2010
1	EnzymesIBA 04/2010
1	Small Molecule LibrariesIBA 07/2004
1	Antidepressive Agents (Antidepressants)IBA 07/2004
1	Pharmaceutical PreparationsIBA 07/2004
1	Formaldehyde (Formol)FDA Link 07/2004
1	GalaninIBA 07/2004
1	Galanin Receptors (Galanin Receptor)IBA 07/2004
1	galmicIBA 07/2004

Therapy/Procedure

1	Therapeutics 04/2010